Cargando…
The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
An increased aspartate aminotransferase-to-alanine aminotransferase ratio (AAR) has been widely used as a marker of advanced hepatic fibrosis. Increased AAR was also shown to be significantly associated with the risk of developing cardiovascular (CV) disease. The aim of this study was to assess the...
Autores principales: | Zoppini, Giacomo, Cacciatori, Vittorio, Negri, Carlo, Stoico, Vincenzo, Lippi, Giuseppe, Targher, Giovanni, Bonora, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089086/ https://www.ncbi.nlm.nih.gov/pubmed/27787357 http://dx.doi.org/10.1097/MD.0000000000004821 |
Ejemplares similares
-
Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization
por: Liu, Chang, et al.
Publicado: (2017) -
Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021) -
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015) -
Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016) -
Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
por: von Felden, Johann, et al.
Publicado: (2020)